Dr. Mark Hoffman, MD
Lijmc-Oncology Pavilion, 270-05 76th Avenue, New Hyde Park, NY 11040 • +1-306-555-2284
Medical Education: Accredited U.S. Medical School (Class of 1994)
What This Doctor Actually Performs: CMS Medicare Utilization & New Hyde Park Percentiles
NPI #1164593257 • CBSA Regional • Hematology-Oncology
Dr. Mark Hoffman, MD (NPI #1164593257) practices Hematology-Oncology in New Hyde Park, NY (11040) with sub-specialty concentration in 128 Active CMS HCPCS Codes, recording 69,471 annual CMS services across 424 distinct beneficiaries—placing this practice as a upper-quartile active clinical volume (86.36th New Hyde Park percentile) (+0.22σ vs NY state mean, 74.44th statewide percentile).
Granular CPT/HCPCS billing distribution at Lijmc-Oncology Pavilion, 270-05 76th Avenue shows Dr. Mark Hoffman's primary concentration in Moderate-to-High Complexity Internal Medicine Follow-Up (code 99214: 2353x/yr, 86.36th local percentile) alongside Established Preventive & Chronic Care Visit (99213: 1360x/yr, $37–$52).
Cash-pay intake data for NPI 1164593257 (Lijmc-Oncology Pavilion, 270-05 76th Avenue, New Hyde Park) indicates $232.00 typical out-of-pocket visit spend against a $232.00 locality benchmark, paired with 16-minute average reception wait and 4.52/5 biomarker openness.
NPI registry verification (#1164593257) confirms Dr. Mark Hoffman's MD standing serving CBSA 11040 with a 4.93/5 patient scorecard.
Compared against New Hyde Park, NY Hematology-Oncology peers
69,471 annual services across 424 beneficiaries
Standard deviations from NY Hematology-Oncology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Moderate-to-High Complexity Internal Medicine Follow-Up | 2,353 | 86.36th | $48 – $66 |
| 99213 | Established Preventive & Chronic Care Visit | 1,360 | 87.36th | $37 – $52 |
| 93000 | In-Office 12-Lead Resting Electrocardiogram | 680 | 91.36th | $25 – $40 |
| G0439 | Annual Preventive Wellness & Cardiometabolic Risk Assessment | 523 | 81.36th | $57 – $78 |
| 99204 | Comprehensive New Patient Internal Medicine Diagnostic Visit | 314 | 91.36th | $67 – $92 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (128 HCPCS billing breadth) | 64,242 | 86.36th | $45 – $65 |
Are you Dr. Mark Hoffman? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in New Hyde Park, NY:
<a href="https://dotmd.com/doctors/mark-hoffman-md-new-hyde-park-ny-1164593257" title="Dr. Mark Hoffman, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1164593257.svg" alt="Dr. Mark Hoffman Hematology-Oncology Badge" width="280" height="72" /></a>
Dr. Mark Hoffman, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Hoffman National Provider Identifier | NPI #1164593257 (MD) | CMS NPPES Registry (11040) |
| Dr. Hoffman New Hyde Park CMS Volume Rank | 86.36th Pct (69,471 CMS svcs; Z +0.221σ) | CMS Medicare Part B (NY Hematology-Oncology) |
| Fair Cash-Pay New-Patient Benchmark | $232.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (New Hyde Park, NY) |
| Waiting-Room Wait Time & Cash Friendliness | $232.00 avg paid • 16 min lobby wait | 8 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.85/5 Listening • 4.52/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Mark Hoffman
Other High-Volume Hematology-Oncology Specialists in New Hyde Park, NY
Ranked strictly by CMS Medicare volumeDr. Hoffman Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in New Hyde Park, NY.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Mark Hoffman community threads and patient logs by age, biological sex, dosage, and treatment duration.